Document Detail

Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP).
MedLine Citation:
PMID:  16738841     Owner:  NLM     Status:  In-Process    
Psoriatic onycho-pachydermo-periostitis (POPP)is a rare subset of psoriatic arthritis, characterized by onychopathy, painful thickening of the periungual soft tissues, and radiological features consisting of an exuberant periosteal reaction of the terminal phalanx. The POPP treatment is debated, and side effect risk of therapies may not be offset by their benefits. We report on a successful treatment with carnitine in a 15-year old boy suffering from POPP.
Pieranna Fietta; Paolo Manganelli
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical rheumatology     Volume:  26     ISSN:  0770-3198     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2011-12-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  93-4     Citation Subset:  IM    
Osteo-Articular Department, Rheumatic Disease and Internal Medicine Unit, Hospital and University of Parma,Via Gramsci, 14,43100 Parma, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Echocardiographic findings mimicking type A aortic dissection.
Next Document:  An unusual case of osteoid osteoma clinically mimicking sacroiliitis.